99 results on '"Puhlmann, M."'
Search Results
2. S200: IMPROVED OVERALL SURVIVAL WITH FIRST-LINE BRENTUXIMAB VEDOTIN PLUS CHEMOTHERAPY IN PATIENTS WITH STAGE III/IV CLASSICAL HODGKIN LYMPHOMA: 6-YEAR ANALYSIS OF ECHELON-1
3. P1089: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE (AN+AD) FOR ADVANCED STAGE CLASSIC HODGKIN LYMPHOMA: PRELIMINARY SAFETY AND EFFICACY RESULTS FROM THE PHASE 2 STUDY (SGN35 027 PART B)
4. The ECHELON-2 Trial:5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
5. Retroperitoneale Weichteilsarkome
6. Modelling the carbon budget of intensive forest monitoring sites in Germany using the simulation model BIOME-BGC
7. ECHELON-2 (NCT01777152), A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF BRENTUXIMAB VEDOTIN plus CHP VS CHOP IN PREVIOUSLY UNTREATED PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMA: 5-YEAR RESULTS
8. Morphometrische Untersuchung von Mikroradiographien der Spongiosatransplantation im Vergleich zur teildemineralisierten Knochenmatrix
9. Diagnostische Probleme bei der akuten Appendizitis und die Indikation zur laparoskopischen Appendektomie
10. Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression
11. Bedeutung des Tumordebulkings bei gastrointestinalen Tumoren
12. Seltene Tumoren der Bauchhöhle: Retroperitoneale Weichteilsarkome
13. Grauwert-Bildanalyse von Mikroradiographie-Präparaten
14. Subgroup analyses from KEYNOTE-045: Pembrolizumab (pembro) versus individual investigator’s choice of chemotherapy (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (uc)
15. Pembrolizumab (pembro) versus paclitaxel, docetaxel, or vinflunine for recurrent, advanced urothelial cancer (UC): Mature results from the phase 3 KEYNOTE-045 trial
16. Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study
17. KEYNOTE-100: Phase 2 trial of pembrolizumab in patients with advanced recurrent ovarian cancer
18. LBA37_PR - Pembrolizumab (pembro) versus paclitaxel, docetaxel, or vinflunine for recurrent, advanced urothelial cancer (UC): Mature results from the phase 3 KEYNOTE-045 trial
19. 851PD - Subgroup analyses from KEYNOTE-045: Pembrolizumab (pembro) versus individual investigator’s choice of chemotherapy (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (uc)
20. 3LBA - Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study
21. Auswirkungen langjähriger Staub- und Schwefeleinträge in nordostdeutsche Kiefernökosysteme
22. 900TiP - KEYNOTE-100: Phase 2 trial of pembrolizumab in patients with advanced recurrent ovarian cancer
23. Comparison of methods for the estimation of inert carbon suitable for initialisation of the CANDY model
24. Dynamics of water, carbon and nitrogen in an agricultural used Chernozem soil in Central Germany
25. Comparison of methods for the estimation of inert carbon suitable for initialisation of the CANDY model
26. A Phase 1b Study of AMG 386 Plus Paclitaxel and Carboplatin in Ovarian Cancer Patients Undergoing Primary or Interval Debulking Surgery
27. AMG 386 in combination with sorafenib in patients (pts) with metastatic renal cell cancer (mRCC): A randomized, double-blind, placebo-controlled, phase II study.
28. Bewertung der Umweltverträglichkeit von Bewirtschaftungssystemen im Hinblick auf die Versorgung der Böden mit organischer Sustanz
29. Bedeutung des CHWL für die NO3-Auswaschung unter Acker
30. Stickstoff - ein Nährstoff aus dem Gleichgewicht
31. Potential for optimisation of carbon and nitrogen dynamics on black earth in Central Germany and N-turnover
32. Auswirkungen der Variabilität ausgewählter Eingangsparameter auf die Unschärfe der mit CANDY simulierten Bodenfeuchte und N-Mineralisierung unter Acker
33. Quantum decay of an open chaotic system: A semiclassical approach
34. Heterogeneous adaptive component-based applications with Adaptive.Net.
35. Tumor-Specific Gene Delivery Using Recombinant Vaccinia Virus in a Rabbit Model of Liver Metastases
36. Spatial Variability of Canopy Throughfall and Groundwater Sulfate Concentrations under a Pine Stand
37. Sterilization of Partially Demineralized Bone Matrix: The Effects of Different Sterilization Techniques on Osteogenetic Properties
38. AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: a randomized, double-blind, placebo-controlled, phase 2 study.
39. The effect of long-term tamoxifen therapy on bone remodelling
40. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice
41. Sensitization of tumor necrosis factor α-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte- activating polypeptide II using recombinant vaccinia virus
42. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus
43. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice
44. Heterogeneous Adaptive Component-Based Applications with Adaptive.Net
45. Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity.
46. Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2.
47. Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma.
48. Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor.
49. The role of interleukin 1 in growth and metastasis of human cancer xenografts.
50. Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.